Qi3 Ventures

Qi3 Ventures, based in Cambridge, United Kingdom, is an investment firm that evolved from Qi3 Accelerator, focusing on early-stage companies in sectors such as space, high-value manufacturing, healthcare and life sciences, and e-commerce. Established in 2011, Qi3 Ventures provides financial investment along with business development and technical expertise to facilitate the rapid commercialization of products and services. The firm caters to entrepreneurs who require both capital and specialized support from experienced professionals. Led by investor Nathan Hill, Qi3 Ventures collaborates with a network of technology experts and investors, enabling the formation of flexible teams to assess and enhance business propositions. Additionally, the firm is connected to various Business Angel networks, including Cambridge Angels and London Business Angels, to bolster its investment capabilities.

Nathan Hill

Founder and CEO

10 past transactions

Honest Grapes

Seed Round in 2015
Honest Grapes is a wine marketplace focused on providing quality and value sourced from independent growers. The company specializes in offering a diverse selection of hand-picked wines, catering to a wide range of preferences. It emphasizes customer convenience by providing free next-day delivery options, allowing wine enthusiasts to easily access quality products online. Additionally, Honest Grapes is committed to assisting customers with their wine-related inquiries, ensuring a knowledgeable and supportive shopping experience.

Blu Wireless

Seed Round in 2013
Blu Wireless Technology is a Silicon IP company focused on developing 60GHz baseband technology to support the WiGig standard and 4G backhaul applications. The company targets power-sensitive mobile applications and long-range access points, offering its technology as a comprehensive System IP solution. Blu Wireless's technology achieves data rates in excess of multiple gigabits per second and can transmit over distances greater than 300 meters. With a strong emphasis on sophisticated system expertise, the company combines mmWave silicon IP with deep domain knowledge in the market, ensuring that partners and customers can rely on their ability to deliver unique and innovative products in a cost-effective and timely manner.

Ecomnova

Seed Round in 2013
Ecomnova Limited operates as an e-commerce Web design and development, and marketing company. It develops and maintains white label gifting Websites for retailers and partners; and retail marketing platform that provides user experience personalization, real-time user tracking, product personalization, and conversion rate optimization. The company serves retailers, wholesalers/manufacturers, and publishers in the United Kingdom. Ecomnova Limited was formerly known as Beaulily Trading Limited. The company was founded in 2012 and is based in Manchester, United Kingdom.

Vantage Power

Series A in 2013
Vantage Power Ltd. specializes in the design and manufacture of electric and hybrid systems for buses and heavy-duty vehicles. The company offers a range of hybrid and electric powertrain solutions, including hybrid battery systems, drive systems, range extenders, and custom battery solutions. Vantage Power focuses on retrofitting existing buses with hybrid powertrains, allowing operators to significantly reduce fuel consumption and emissions without the high costs associated with purchasing new hybrid vehicles. The company's engineering team, composed of experts from the heavy-duty vehicle, Formula 1, and aerospace industries, is dedicated to developing innovative technologies that ensure optimal performance and reliability. Established in 2011 and based in London, Vantage Power operates as a subsidiary of Allison Transmission Holdings, Inc.

Arquer Diagnostics

Seed Round in 2012
Arquer Diagnostics Ltd. specializes in the design, development, and commercialization of non-invasive immunoassay diagnostic tests for bladder and prostate cancer. The company offers an enzyme-linked immunosorbent assay (ELISA) for measuring small amounts of substances in body fluids, including a CE-marked ELISA kit for Mcm5, which is utilized in hospital pathology laboratories. Additionally, Arquer provides a point-of-care system that features a robust reader instrument and disposable cartridges, allowing for immediate testing in urology clinics, hospital laboratories, and general practitioners' surgeries. Founded in 2005 and formerly known as UroSens Ltd., the company is headquartered in Sunderland, United Kingdom, and is committed to improving cancer detection and monitoring to enhance patient outcomes.

LumeJet

Angel Round in 2012
LumeJet Print Technologies Limited is a company based in Coventry, United Kingdom, that specializes in the design, development, and manufacture of ultra-high resolution printers tailored for production environments. These printers are utilized for various applications, including layflat books, fine art prints, pitches and proposals, book jackets, and wedding albums. Additionally, LumeJet's technology supports inkless printing for labeling and packaging, printed electronics, and direct-write digital lithography for photomasking on printed circuit boards and flexible substrates. The company distributes its products through a network across Europe and North America. Established in 2009, LumeJet was previously known as LumeJet Limited before rebranding in September 2015.

Isotera

Venture Round in 2012
Isotera is a UK-based specialist in LED lighting, led by CEO Marc Ottolini. The company has developed an innovative intelligent LED lighting system that enhances the performance of LED lights while simplifying installation processes, making them more cost-effective. Isotera collaborates with various stakeholders in the global lighting supply chain to provide comprehensive solutions for contractors and system integrators. Their focus on energy-efficient lighting aims to streamline installation by eliminating the need for individual drivers, thereby offering significant benefits to end-users.

Lintbells

Venture Round in 2012
Lintbells Ltd. is a manufacturer and supplier of natural nutritional health supplements for cats and dogs, established in 2006 and based in Weston, United Kingdom. The company offers a diverse range of products aimed at enhancing pet health, including joint health and mobility supplements, coat growth and recovery aids, skin health products, energy boosters, digestive support, and antibacterial solutions. Lintbells is recognized for its leading brands, YuMOVE and YuMEGA, which are the top joint mobility and skin and coat supplements in the UK, respectively. The company distributes its products online and through various channels, including pet stores, veterinarians, groomers, hydrotherapy centers, and country stores, ensuring accessibility for pet owners seeking to support their pets' health and well-being.

Cipher Surgical

Seed Round in 2011
Cipher Surgical Limited is a medical device company based in Coventry, United Kingdom, founded in 2010. The company specializes in the design and development of laparoscopic medical devices, particularly focusing on maintaining a clear view during surgical procedures. Its flagship product, OpClear, is a sterile disposable unit that employs in-situ carbon dioxide and saline to provide a solution for distal window contamination throughout laparoscopic surgeries. This innovation enhances the efficiency and safety of minimally invasive procedures, allowing surgeons to perform abdominal keyhole surgery more effectively. Cipher Surgical aims to patent and globally market its unique devices, contributing to advancements in surgical practices.

Cytox

Seed Round in 2009
Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.